1: Calabrese G, Fantasia D, Di Gianfilippo R, Stuppia L, Di Lorenzo R, Palka G. Fluorescence in situ hybridization analysis of minimal residual disease and the relevance of the der(9) deletion in imatinib-treated patients with chronic myeloid leukemia. Haematologica. 2006 Jul;91(7):994-5. PMID: 16818290 [PubMed - indexed for MEDLINE] 2: Franceschino A, Tornaghi L, Piazza R, Pogliani E, Gambacorti Passerini C. Imatinib failed to eradicate chronic myeloid leukemia in a patient with minimal residual disease. Haematologica. 2006 Jun;91(6 Suppl):ECR14. No abstract available. PMID: 16785120 [PubMed - indexed for MEDLINE] 3: Thorn I, Olsson-Stromberg U, Ohlsen C, Jonsson AM, Klangby U, Simonsson B, Barbany G. The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia. Haematologica. 2005 Nov;90(11):1471-6. PMID: 16266893 [PubMed - indexed for MEDLINE] 4: Uzunel M, Mattsson J, Brune M, Johansson JE, Aschan J, Ringden O. Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantation. Blood. 2003 Jan 15;101(2):469-72. Epub 2002 Aug 29. PMID: 12393598 [PubMed - indexed for MEDLINE]
LLama Gratis a cualquier PC del Mundo.
Llamadas a fijos y móviles desde 1 céntimo por minuto.
http://es.voice.yahoo.com
No hay comentarios:
Publicar un comentario